Killebrew, Deirdre A.
Williams, Kimberly S.
Xie, Youmei
Longo, Frank
Meeker, Rick B. http://orcid.org/0000-0002-7487-5315
Funding for this research was provided by:
National Institutes of Health (R01 NS083164, R01 MH085606, R21 AG056924, F31 MH101019, F32 HL085025)
Article History
Received: 15 January 2021
Accepted: 22 June 2021
First Online: 22 July 2021
Declarations
:
: Dr. Longo, co-author, is listed as an inventor on patents relating to a compound in this report that is assigned to the University of North Carolina. Dr. Longo is a principal of, and has financial interest in PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors that has licensed several of these patents. Dr. Longo provided the compound, LM11A-31, for these studies as an unrestricted gift. He consulted on the use of the compound and reviewed the manuscript but did not participate in the design or conduction of any experiments.